Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2006; 12(4): 603-607
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.603
Table 1 Characteristics of patients (n=31)
CharacteristicsNumber of (%) patients
Age (yr)
Median51.9
Range24-70
Sex
Male21 (67.8)
Female10 (32.2)
Type of operation
Radical subtotal gastrectomy16 (51.6)
Radical total gastrectomy15(48.4)
Location
Antrum17 (54.8)
Corpus9 (29.0)
Cardia5 (16.1)
Lauren classification
Diffuse20 (64.5)
Intestinal6 (19.4)
Mixed5 (16.1)
Borrmann type
I1 (3.2)
II4 (12.9)
III18 (58.1)
IV8 (25.8)
Stage
IIIA11 (35.5)
T2bN22 (6.5)
T3N19 (29.0)
IIIB14 (45.2)
T3N214 (45.2)
IV (M0)6 (19.4)
T4N21 (3.2)
T2bN31 (3.2)
T3N34 (13.0)
Number of positive nodes
Median9
Range1-49
Table 2 Reasons for the cessation of chemoradiotherapy (n=8)
Reasons for cessationNumber of patients (%)
Protocol treatment completed23 (74.2)
Toxic effects6 (19.3)
during chemoradiotherapy2 (6.4)
during maintenance chemotherapy4 (12.9)
Patients declined further chemotherapy2 (6.4)
Table 3 Major toxic effects1 of chemoradiotherapy
Type of toxic effectsNumber of patients (%)
Hematologic anemia4 (12.9)
Neutropenia15 (50.2)
Thrombocytopenia1 (3.2)
Nausea/Vomiting1 (3.2)
Diarrhea1 (3.2)
Adhesive ileus requiring operation2 (6.4)
Table 4 Sites of relapse (n=8)1
SiteNumber of patients with relapse (%)
Locoregional23 (9.7)
Peritoneal32 (6.4)
Distant43 (9.7)